Galectin Therapeutics (GALT)
(Delayed Data from NSDQ)
$3.37 USD
-0.01 (-0.30%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $3.37 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/20/2024
Time: -- |
3/2024 | $-0.16 | 0.00% |
Earnings Summary
For their last quarter, Galectin Therapeutics (GALT) reported earnings of -$0.16 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for GALT's next earnings release expected on May 20, 2024. For the next earning release, we expect the company to report earnings of -$0.16 per share, reflecting a year-over-year increase of 15.79%.
Earnings History
Price & Consensus
Zacks News for GALT
What Makes Galectin Therapeutics Inc. (GALT) a New Buy Stock
GALT: What are Zacks experts saying now?
Zacks Private Portfolio Services